Your browser doesn't support javascript.
loading
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.
Douglas, Kenneth W; Gilleece, Maria; Hayden, Patrick; Hunter, Hannah; Johnson, Peter R E; Kallmeyer, Charlotte; Malladi, Ram K; Paneesha, Shankara; Pawson, Rachel; Quinn, Michael; Raj, Kavita; Richardson, Deborah; Robinson, Stephen; Russell, Nigel; Snowden, John; Sureda, Anna; Tholouli, Eleni; Thomson, Kirsty; Watts, Mike; Wilson, Keith M.
Affiliation
  • Douglas KW; Clinical Apheresis Unit, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Gilleece M; Yorkshire Blood and Marrow Transplant Programme, Leeds Teaching Hospitals, Leeds, United Kingdom.
  • Hayden P; Haematology Department, St James's Hospital, Dublin, Ireland.
  • Hunter H; Haematology Department, Derriford Hospital, Plymouth Hospitals NHS Trust, Plymouth, United Kingdom.
  • Johnson PRE; Department of Haematology, Western General Hospital, Edinburgh, United Kingdom.
  • Kallmeyer C; Department of Haematology, Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom.
  • Malladi RK; Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom.
  • Paneesha S; Department of Haematology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom.
  • Pawson R; Tissue Services and Cell Banking, NHS Blood and Transplant, Bristol, United Kingdom.
  • Quinn M; Department of Haematology, Belfast NHS Trust, Belfast, United Kingdom.
  • Raj K; Haematological Cancer Services, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Richardson D; Department of Haematology, University Hospital Southampton, Southampton, United Kingdom.
  • Robinson S; Bristol Haematology Unit, University Hospitals Bristol, Bristol, United Kingdom.
  • Russell N; Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom.
  • Snowden J; Department of Haematology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.
  • Sureda A; Department of Haematology, Institut Catalá d'Oncologia, Barcelona, Spain.
  • Tholouli E; HSC Transplant Services, Department of Haematology, Central Manchester University Hospitals, Manchester, United Kingdom.
  • Thomson K; Department of Clinical Haematology, University College Hospitals, London, United Kingdom.
  • Watts M; Wolfson Cellular Therapies Unit, University College Hospitals, London, United Kingdom.
  • Wilson KM; Department of Haematology, Cardiff & Vale University Health Board, Cardiff, United Kingdom.
J Clin Apher ; 33(1): 46-59, 2018 Feb.
Article in En | MEDLINE | ID: mdl-28631842
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Mobilization / Consensus / Chemoradiotherapy / Heterocyclic Compounds / Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Clin Apher Year: 2018 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Mobilization / Consensus / Chemoradiotherapy / Heterocyclic Compounds / Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Clin Apher Year: 2018 Type: Article Affiliation country: United kingdom